# Point-of-Care System for Determination of Bilirubin Capacity in Neonates

> **NCT02612207** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 161 (actual)

## Conditions studied

- Jaundice, Neonatal
- Hyperbilirubinemia
- Bilirubin-Induced Neurological Dysfunction (BIND)

## Interventions

- **DEVICE:** Bilirubin Binding Capacity by Hematofluorometry Validation

## Key facts

- **NCT ID:** NCT02612207
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-01
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612207, "Point-of-Care System for Determination of Bilirubin Capacity in Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02612207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*